ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,180.49
-1.14%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.651
-0.02%
Brent Oil
83.76
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Calmare Therapeutics Inc (CE) (CTTC)

  7. Calmare Therapeutics Inc (CE) (CTTC) ニュース

CTTC

Calmare Therapeutics (CE) (CTTC)

Calmare Therapeutics Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:CTTC
日付受信時刻ニュースソース見出しコード企業名
2020/06/1006 : 27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2020/02/1205 : 19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/11/0606 : 55Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/07/2003 : 37Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/06/1305 : 58Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/06/1105 : 18Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/06/0402 : 17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/03/2600 : 56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/03/1904 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2019/02/1502 : 34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/07/0307 : 28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/07/0307 : 14Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/06/1519 : 08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/06/1519 : 08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/05/0419 : 17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/05/0419 : 17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/03/0703 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/03/0703 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/03/0703 : 09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/2023 : 47Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/2020 : 33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/2020 : 32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1707 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1702 : 06Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1620 : 09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1620 : 09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1420 : 56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1403 : 43Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/02/1005 : 08Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
2018/01/1707 : 16Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:CTTC

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
CCOM
US500
US 500
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
CCOM
US100
US Tech 100
NYSE
CVX
Chevron
NYSE
JPM
JP Morgan Chase
FX
USDEUR
US Dollar vs Euro
FX
USDGBP
US Dollar vs Sterling
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有